Interleukin 12 receptor is a type I cytokine receptor, binding interleukin 12 and consisting of beta 1[1] and beta 2 subunits.[2]
References
- ^ Chua AO, Chizzonite R, Desai BB, Truitt TP, Nunes P, Minetti LJ, Warrier RR, Presky DH, Levine JF, Gately MK (1994). "Expression cloning of a human IL-12 receptor component. A new member of the cytokine receptor superfamily with strong homology to gp130". J. Immunol. 153 (1): 128–36. doi:10.4049/jimmunol.153.1.128. PMID 7911493. S2CID 9211163.
- ^ Presky DH, Yang H, Minetti LJ, Chua AO, Nabavi N, Wu CY, Gately MK, Gubler U (1996). "A functional interleukin 12 receptor complex is composed of two beta-type cytokine receptor subunits". Proc. Natl. Acad. Sci. U.S.A. 93 (24): 14002–14007. Bibcode:1996PNAS...9314002P. doi:10.1073/pnas.93.24.14002. PMC 19484. PMID 8943050.
External links
|
---|
IL-1 |
- Antagonists: AF-12198
- Anakinra
- IL-1RA
- Isunakinra
- Antibodies: Canakinumab
- Gevokizumab
- Lutikizumab
- Decoy receptors: Rilonacept (IL-1 Trap)
|
---|
IL-2 |
- Agonists: Adargileukin alfa
- Aldesleukin
- Celmoleukin
- Denileukin diftitox
- Interleukin 2
- Pegaldesleukin
- Teceleukin
- Tucotuzumab celmoleukin
- Antibodies: Basiliximab
- Daclizumab (dacliximab)
- Inolimomab
|
---|
IL-3 | |
---|
IL-4 |
- Antibodies: Dupilumab
- Pascolizumab
|
---|
IL-5 |
- Antibodies: Benralizumab
- Mepolizumab
- Reslizumab
- Antisense oligonucleotides: TPI ASM8
|
---|
IL-6 |
- Antibodies: ARGX-109
- Clazakizumab
- Elsilimomab
- mAb 1339
- Olokizumab
- Sarilumab
- Siltuximab
- Sirukumab
- Tocilizumab
- Levilimab
|
---|
IL-7 | |
---|
IL-8 |
- See CXCR1 (IL-8Rα) and CXCR2 (IL-8Rβ) here instead.
|
---|
IL-9 | |
---|
IL-10 | |
---|
IL-11 | |
---|
|
- Antibodies: Briakinumab
- Ustekinumab
|
---|
IL-13 |
- Antibodies: Anrukinzumab
- Lebrikizumab
- Tralokinumab
|
---|
IL-15 | |
---|
IL-17 |
- Antibodies: Brodalumab
- Ixekizumab
- Perakizumab
- Remtolumab
- Secukinumab
- Vunakizumab
|
---|
IL-18 | |
---|
IL-20 |
- Antibodies: Fletikumab (against IL-20)
|
---|
IL-21 |
- Antibodies: NNC0114-0005
- NNC0114-0006
|
---|
IL-22 |
- Antibodies: Fezakinumab (against IL-22)
|
---|
IL-23 |
- Agonists: Interleukin 23 (SGRF)
- Antibodies: Brazikumab
- Briakinumab
- Guselkumab
- Risankizumab
- Tildrakizumab
- Ustekinumab
|
---|
IL-27 | |
---|
IL-28 | |
---|
IL-31 | |
---|
IL1RL1 | |
---|
IL1RL2 | |
---|
Others | JAK | |
---|
Others |
- Unsorted: Efavaleukin alfa
- Efineptakin alfa
|
---|
|
---|